Yorktown Management & Research CO Inc Regeneron Pharmaceuticals, Inc. Transaction History

Yorktown Management & Research CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	BUY	$472.8 - $558.54 $226,944 - $268,099	480 New	480 $268,000
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $239,150 - $303,990	-500 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$336.18 - $494.43 $218,517 - $321,379	-650 Reduced 56.52%	500 $244,000
Q4 2019 Jan 27, 2020	BUY	$274.13 - $376.51 $315,249 - $432,986	1,150 New	1,150 $432,000
Q2 2019 Aug 02, 2019	SELL	$299.6 - $414.82 $209,720 - $290,374	-700 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	700	700 $344,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

Stay updated on Yorktown Management & Research CO Inc with notifications on news.